Sana Biotechnology, Inc. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer
Sana Biotechnology, Inc. (SANA) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer of $5.98 million as of 2024-03-31, per its 10-Q filed 2024-05-08.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger · last filed 2024-11-08
- 2024-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $5.98M.
- 2023-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $10.39M.
- 2023-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $26.71M.
- 2023-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $91.59M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer |
|---|---|
| 2024-03-31 | $5.98M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $10.39M 10-Q · filed 2024-11-08 |
| 2023-09-30 | $26.71M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $91.59M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $141.79M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $192.51M 10-K · filed 2024-02-29 |
| 2022-09-30 | $228.59M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $3.05M 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |